Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M44,685Revenue $M5,770Net Margin (%)6.3Z-Score1.6
Enterprise Value $M60,262EPS $-2.7Operating Margin %20.2F-Score7
P/E(ttm))91.3Cash Flow Per Share $4.9Pre-tax Margin (%)5.4Higher ROA y-yY
Price/Book8.710-y EBITDA Growth Rate %2.9Quick Ratio1.1Cash flow > EarningsY
Price/Sales5.65-y EBITDA Growth Rate %42.8Current Ratio1.4Lower Leverage y-yY
Price/Cash Flow11.8y-y EBITDA Growth Rate %164ROA % (ttm)1.8Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)10.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M334ROI % (ttm)-4.0Gross Margin Increase y-yY

Gurus Latest Trades with VRX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRXGlenn Greenberg 2014-06-30 Add2.33%$116.99 - $138.13
($127.6)
$ 131.513%Add 8.19%6,050,442
VRXAndreas Halvorsen 2014-06-30 Add1.39%$116.99 - $138.13
($127.6)
$ 131.513%Add 27.27%11,830,932
VRXSteve Mandel 2014-06-30 Add0.64%$116.99 - $138.13
($127.6)
$ 131.513%Add 14.44%10,089,450
VRXLee Ainslie 2014-06-30 Add0.37%$116.99 - $138.13
($127.6)
$ 131.513%Add 8.39%2,625,014
VRXGeorge Soros 2014-06-30 Add0.29%$116.99 - $138.13
($127.6)
$ 131.513%Add 185.46%472,187
VRXChris Davis 2014-06-30 Add0.17%$116.99 - $138.13
($127.6)
$ 131.513%Add 16.03%3,153,748
VRXJoel Greenblatt 2014-06-30 Buy 0.01%$116.99 - $138.13
($127.6)
$ 131.513%New holding, 6172 sh.6,172
VRXDaniel Loeb 2014-06-30 Sold Out -0.48%$116.99 - $138.13
($127.6)
$ 131.513%Sold Out0
VRXJohn Paulson 2014-06-30 Reduce-0.32%$116.99 - $138.13
($127.6)
$ 131.513%Reduce -49.97%500,300
VRXWallace Weitz 2014-06-30 Reduce-0.19%$116.99 - $138.13
($127.6)
$ 131.513%Reduce -2.91%1,551,076
VRXMariko Gordon 2014-06-30 Sold Out -0.13%$116.99 - $138.13
($127.6)
$ 131.513%Sold Out0
VRXLee Ainslie 2014-03-31 Add1.46%$112.62 - $148
($136.19)
$ 131.51-3%Add 48.23%2,421,778
VRXChris Davis 2014-03-31 Add0.95%$112.62 - $148
($136.19)
$ 131.51-3%Add 2686.89%2,718,162
VRXJohn Paulson 2014-03-31 Buy 0.65%$112.62 - $148
($136.19)
$ 131.51-3%New holding, 1000000 sh.1,000,000
VRXSteve Mandel 2014-03-31 Add0.61%$112.62 - $148
($136.19)
$ 131.51-3%Add 13.67%8,816,702
VRXAndreas Halvorsen 2014-03-31 Add0.53%$112.62 - $148
($136.19)
$ 131.51-3%Add 11.61%9,296,143
VRXDaniel Loeb 2014-03-31 Buy 0.48%$112.62 - $148
($136.19)
$ 131.51-3%New holding, 250000 sh.250,000
VRXGeorge Soros 2014-03-31 Buy 0.22%$112.62 - $148
($136.19)
$ 131.51-3%New holding, 165411 sh.165,411
VRXGlenn Greenberg 2014-03-31 Reduce-2.5%$112.62 - $148
($136.19)
$ 131.51-3%Reduce -8.52%5,592,558
VRXWallace Weitz 2014-03-31 Reduce-0.99%$112.62 - $148
($136.19)
$ 131.51-3%Reduce -13.61%1,597,540
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
VRX Joel Greenblatt 2014-06-306,17200.01New Buy
VRX George Soros 2014-06-30472,1870.140.45+185.46%
VRX Andreas Halvorsen 2014-06-3011,830,9323.556.5+27.27%
VRX Chris Davis 2014-06-303,153,7480.951.2+16.03%
VRX Steve Mandel 2014-06-3010,089,4503.025.1+14.44%
VRX Jean-Marie Eveillard 2014-06-301,024,4020.310.31+13.5%
VRX Lee Ainslie 2014-06-302,625,0140.794.8+8.39%
VRX Glenn Greenberg 2014-06-306,050,4421.8130.8+8.19%
VRX Ruane Cunniff 2014-06-3034,298,38410.2823.1+0.24%
VRX Lou Simpson 2014-06-301,615,5490.488.2+0.06%
VRX Jeff Ubben 2014-06-3018,923,8775.6717.6
VRX Private Capital 2014-06-30300,4460.094.3-1.02%
VRX Wallace Weitz 2014-06-301,551,0760.465.9-2.91%
VRX John Paulson 2014-06-30500,3000.150.27-49.97%
VRX Daniel Loeb 2014-06-30000Sold Out
VRX Mariko Gordon 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


VRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy. 2014-06-23Sell10,203$121.76.62view
Mirovsky PavelPresident of Valeant Europe 2014-06-02Sell10,000$131.25-1.14view
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy. 2014-05-13Sell10,000$130.08-0.25view
Provencio Norma AnnDirector 2014-04-01Sell5,000$132.18-1.83view
Kornwasser LaizerEVP, Company Group Chairman 2014-03-21Buy2,481$134.97-3.86view
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy. 2014-03-17Sell5,000$141.72-8.44view
Provencio Norma AnnDirector 2014-03-03Sell5,000$141.62-8.37view
Provencio Norma AnnDirector 2014-02-03Sell5,000$136.23-4.75view
Kornwasser LaizerEVP, Company Group Chairman 2014-01-24Buy2,536$132.15-1.81view
Provencio Norma AnnDirector 2014-01-13Sell5,000$133-2.44view

Press Releases about VRX :

    Quarterly/Annual Reports about VRX:

    News about VRX:

    Articles On GuruFocus.com
    Wallace Weitz's Partners Value Fund Q3 2014 Commentary Oct 16 2014 
    Ackman's Pershing Square Now Available To The Public Oct 13 2014 
    Bill Ackman and Valeant Could Sweeten Allergan Deal By $15 A Share Oct 10 2014 
    Wallace Weitz's Value Fund Q2 Commentary Oct 06 2014 
    Transcript of Ruane, Cunniff & Goldfarb Investor Day - May 16, 2014 Oct 05 2014 
    Most Held Canadian Stocks of the Second Quarter Sep 04 2014 
    Valeant Pharmaceuticals Part XII: the rolling solvency calculation Sep 02 2014 
    Valeant Pharmaceuticals part XI: Less luscious lips Aug 13 2014 
    Valeant Pharmaceuticals Part X: a follow up on the sale of facial injectables Aug 11 2014 
    Diamond Hill Capital Comments on Valeant Pharmaceuticals International Inc Jul 25 2014 

    More From Our Partners
    Benzinga's M&A Chatter for Monday October 27, 2014 Oct 27 2014 - BENZINGA

    More From Other Websites
    The Consequences of Saying No to a Hostile Takeover Bid Oct 28 2014
    Ackman-Allergan Enters Courtroom Phase: Opening Line Oct 28 2014
    Stock Market News for October 28, 2014 Oct 28 2014
    Ackman’s $5.3 Billion Allergan Bet Examined Before Vote Oct 27 2014
    Benzinga's M&A Chatter for Monday October 27, 2014 Oct 27 2014
    Takeover drama for your mama: Cramer reveals Oct 27 2014
    Valeant willing to raise offer for Botox maker Allergan Oct 27 2014
    Video: Allergan Lifts Views; Valeant Suggests Higher Bid Oct 27 2014
    Valeant Pharmaceuticals Eyes Raising Allergan Bid to $200 a Share Oct 27 2014
    Valeant Raises Allergan Takeover Bid Oct 27 2014
    Valeant: We'll bump Allergan offer to $200 a share Oct 27 2014
    Valeant: We'll bump Allergan offer to $200 a share Oct 27 2014
    Advising Valeant's hostile bid Oct 27 2014
    Shire (SHPG) Gains on Q3 Earnings Beat, Ups Guidance Oct 27 2014
    Stocks to Watch: Chiquita, Allergan, Merck Oct 27 2014
    Canada Stocks to Watch: Precision Drilling, Performance Sports and more Oct 27 2014
    Allergan Beats on Earnings, Revenues; Valeant Raises Offer Oct 27 2014
    Allergan CEO on the call Oct 27 2014
    ‘Monsters under the bed’ threaten market’s seasonal boost Oct 27 2014
    Pharma fight: What's Allergan worth? Oct 27 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK